drugset / Trial / NCT01375010
Vitamin D HIV Study on Postmenopausal Women
Phase 1/2
Completed
85 enrolled
Columbia University
National Institute of Allergy and Infectious Diseases (NIAID) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to determine the effects of vitamin D on measures of bone health and immune function in HIV infected postmenopausal women. The investigators prior research with this population revealed that low vitamin D levels are very common. Prior research with this population also revealed that Vitamin D is necessary for the body to absorb calcium and is important for the health of the bones. When vitamin D levels are low, there are increased risks of bone loss, muscle weakness, falls and fractures. Low levels of vitamin D have also been associated with impaired immune function. This study will help us learn whether two different doses of vitamin D will improve bone health and immune function.
Timeline
- Start
- 2011-01
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cholecalciferol | Other / unclassified | 1000 iu | — |
| Subject | Cholecalciferol | Other / unclassified | 3000 iu | — |
| Background | Calcium carbonate | Other / unclassified | 1000 mg | — |